Personalis, Inc. – NASDAQ:PSNL
Founder-led company
Personalis stock price today
$4.462
-1.40
-23.99%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
Personalis stock price monthly change
+253.61%
month
Personalis stock price quarterly change
+253.61%
quarter
Personalis stock price yearly change
+189.16%
year
Personalis key metrics
Market Cap | 417.50M |
Enterprise value | 74.85M |
P/E | -1.08 |
EV/Sales | 1.15 |
EV/EBITDA | -0.71 |
Price/Sales | 1.89 |
Price/Book | 0.56 |
PEG ratio | 0.01 |
EPS | -1.9 |
Revenue | 74.14M |
EBITDA | -77.43M |
Income | -92.60M |
Revenue Q/Q | 3.52% |
Revenue Y/Y | 7.95% |
Profit margin | -174.2% |
Oper. margin | -177.61% |
Gross margin | 20.52% |
EBIT margin | -177.61% |
EBITDA margin | -104.44% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePersonalis stock price history
Personalis stock forecast
Personalis financial statements
| Jun 2023 | 16.69M | -23.95M | -143.45% |
|---|---|---|---|
| Sep 2023 | 18.24M | -29.09M | -159.47% |
| Dec 2023 | 19.67M | -26.58M | -135.12% |
| Mar 2024 | 19.52M | -12.96M | -66.42% |
| Sep 2025 | 23.65M | -17.54M | -74.15% |
|---|---|---|---|
| Oct 2025 | 23.30M | -15.77M | -67.69% |
| Dec 2025 | 26.19M | -13.13M | -50.16% |
| Mar 2026 | 26.71M | -23.03M | -86.23% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 249038000 | 72.95M | 29.29% |
|---|---|---|---|
| Sep 2023 | 226636000 | 75.43M | 33.28% |
| Dec 2023 | 225099000 | 95.65M | 42.5% |
| Mar 2024 | 195276000 | 74.58M | 38.19% |
| Jun 2023 | -10.41M | 19.54M | 925K |
|---|---|---|---|
| Sep 2023 | -16.68M | -8.60M | 290K |
| Dec 2023 | -13.41M | -11.63M | 9.81M |
| Mar 2024 | -20.41M | 6.30M | 1.12M |
Personalis alternative data
| Aug 2023 | 395 |
|---|---|
| Sep 2023 | 395 |
| Oct 2023 | 395 |
| Nov 2023 | 395 |
| Dec 2023 | 395 |
| Jan 2024 | 395 |
| Feb 2024 | 395 |
| Mar 2024 | 223 |
| Apr 2024 | 223 |
| May 2024 | 223 |
| Jun 2024 | 223 |
| Jul 2024 | 223 |
Personalis other data
43.46%
-17.08%
of PSNL is owned by hedge funds
36
-44
19.86M
-7.93M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 1242 |
| Mar 2024 | 10000 | 0 |
| Apr 2024 | 0 | 4523 |
| May 2024 | 0 | 4004 |
| Jun 2024 | 0 | 13816 |
| Jul 2024 | 0 | 1266 |
| Aug 2024 | 3500000 | 0 |
| Nov 2024 | 0 | 30364 |
| Dec 2024 | 0 | 13212 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | CHEN RICHARD officer: CHIEF ME.. | Common Stock | 4,834 | $3.82 | $18,466 | ||
Sale | MOORE STEPHEN MICHAEL officer: SVP and Chief Legal Of.. | Common Stock | 1,513 | $3.82 | $5,780 | ||
Sale | TACHIBANA AARON officer: CFO AND .. | Common Stock | 6,865 | $3.82 | $26,224 | ||
Sale | CHEN RICHARD officer: CHIEF ME.. | Common Stock | 921 | $3.79 | $3,491 | ||
Sale | TACHIBANA AARON officer: CFO AND .. | Common Stock | 1,307 | $3.79 | $4,954 | ||
Sale | MOORE STEPHEN MICHAEL officer: SVP and Chief Legal Of.. | Common Stock | 1,693 | $3.79 | $6,416 | ||
Sale | HALL CHRISTOPHER M director, officer: PRESIDENT AN.. | Common Stock | 26,443 | $5.38 | $142,263 | ||
Purchase | TEMPUS AI, INC. 10 percent owner | Common Stock | 3,500,000 | $5.07 | $17,745,000 | ||
Sale | CHEN RICHARD officer: CHIEF ME.. | Common Stock | 524 | $2.97 | $1,556 | ||
Sale | TACHIBANA AARON officer: CFO AND .. | Common Stock | 742 | $2.97 | $2,204 |
| Patent |
|---|
Application Filling date: 3 May 2022 Issue date: 8 Sep 2022 |
Application Filling date: 19 May 2022 Issue date: 1 Sep 2022 |
Application Filling date: 18 May 2022 Issue date: 1 Sep 2022 |
Application Filling date: 17 May 2022 Issue date: 1 Sep 2022 |
Application Filling date: 3 May 2022 Issue date: 18 Aug 2022 |
Grant Filling date: 23 Oct 2020 Issue date: 9 Aug 2022 |
Grant Filling date: 10 Dec 2021 Issue date: 12 Jul 2022 |
Application Filling date: 7 Mar 2022 Issue date: 23 Jun 2022 |
Grant Filling date: 21 Oct 2021 Issue date: 21 Jun 2022 |
Grant Filling date: 20 Apr 2021 Issue date: 12 Apr 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Personalis stock today?
One share of Personalis stock can currently be purchased for approximately $4.46.
-
When is Personalis's next earnings date?
Unfortunately, Personalis's (PSNL) next earnings date is currently unknown.
-
Does Personalis pay dividends?
No, Personalis does not pay dividends.
-
How much money does Personalis make?
Personalis has a market capitalization of 417.50M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.97% to 73.48M US dollars.
-
What is Personalis's stock symbol?
Personalis, Inc. is traded on the NASDAQ under the ticker symbol "PSNL".
-
What is Personalis's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Personalis?
Shares of Personalis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Personalis's key executives?
Personalis's management team includes the following people:
- Mr. John Stephen West Co-Founder, Chief Executive Officer, Pres & Director(age: 68, pay: $1,030,000)
- Dr. Richard Chen M.D., M.S., MS Senior Vice President of R&D and Chief Medical Officer(age: 54, pay: $638,500)
- Mr. Aaron L. Tachibana Senior Vice President & Chief Financial Officer(age: 64, pay: $603,500)
-
Is Personalis founder-led company?
Yes, Personalis is a company led by its founder Mr. John Stephen West.
-
How many employees does Personalis have?
As Jul 2024, Personalis employs 223 workers.
-
When Personalis went public?
Personalis, Inc. is publicly traded company for more then 6 years since IPO on 20 Jun 2019.
-
What is Personalis's official website?
The official website for Personalis is personalis.com.
-
Where are Personalis's headquarters?
Personalis is headquartered at 1330 O’Brien Drive, Menlo Park, CA.
-
How can i contact Personalis?
Personalis's mailing address is 1330 O’Brien Drive, Menlo Park, CA and company can be reached via phone at +65 07521300.
Personalis company profile:
Personalis, Inc.
personalis.comExchange:
NASDAQ
Full time employees:
223
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.
1330 O’Brien Drive
Menlo Park, CA 94025
Menlo Park, CA 94025
CIK: 0001527753
ISIN: US71535D1063
CUSIP: 71535D106
